• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

GM-CSF - an oncogenic driver of HER2+ breast leptomeningeal metastasis.

作者信息

Garg Rachana, Jandial Kai, Chen Mike

出版信息

Oncoscience. 2022 Oct 10;9:57-59. doi: 10.18632/oncoscience.566. eCollection 2022.

DOI:10.18632/oncoscience.566
PMID:36225261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9549905/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00af/9549905/8756819aef3d/oncoscience-09-566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00af/9549905/8756819aef3d/oncoscience-09-566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00af/9549905/8756819aef3d/oncoscience-09-566-g001.jpg

相似文献

1
GM-CSF - an oncogenic driver of HER2+ breast leptomeningeal metastasis.粒细胞-巨噬细胞集落刺激因子——HER2阳性乳腺癌软脑膜转移的致癌驱动因素。
Oncoscience. 2022 Oct 10;9:57-59. doi: 10.18632/oncoscience.566. eCollection 2022.
2
Autocrine GMCSF Signaling Contributes to Growth of HER2 Breast Leptomeningeal Carcinomatosis.自分泌 GMCSF 信号促进 HER2 型乳腺癌脑膜转移瘤的生长。
Cancer Res. 2021 Sep 15;81(18):4723-4735. doi: 10.1158/0008-5472.CAN-21-0259. Epub 2021 Jul 9.
3
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.大剂量环磷酰胺后三种细胞因子方案的比较效果：粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子（GM-CSF）以及白细胞介素-3与GM-CSF序贯治疗。
J Clin Oncol. 1999 Apr;17(4):1296. doi: 10.1200/JCO.1999.17.4.1296.
4
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.粒细胞集落刺激因子与粒细胞-巨噬细胞集落刺激因子联合应用动员造血祖细胞的I/II期研究
J Clin Oncol. 1996 Jan;14(1):277-86. doi: 10.1200/JCO.1996.14.1.277.
5
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.粒细胞-巨噬细胞集落刺激因子（GM-CSF）和粒细胞集落刺激因子（G-CSF）对高剂量化疗后用于自体骨髓的外周血祖细胞启动的比较作用。
Blood. 1993 Apr 1;81(7):1709-19.
6
Granulocyte-macrophage colony-stimulating factor enhances leptomeningeal collateral growth induced by common carotid artery occlusion.粒细胞-巨噬细胞集落刺激因子增强了颈总动脉闭塞诱导的软脑膜侧支生长。
Stroke. 2008 Jun;39(6):1875-82. doi: 10.1161/STROKEAHA.107.503433. Epub 2008 Apr 3.
7
Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2 Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression.抑制 Jumonji 组蛋白去甲基酶通过抑制 GMCSF 表达选择性抑制 HER2 乳腺癌软脑膜转移生长。
Cancer Res. 2021 Jun 15;81(12):3200-3214. doi: 10.1158/0008-5472.CAN-20-3317. Epub 2021 May 3.
8
Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子和肿瘤坏死因子-α刺激人中性粒细胞时，不同的丝裂原活化蛋白激酶亚型级联反应的细胞因子特异性激活。
Blood. 1999 Jan 1;93(1):341-9.
9
Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.人粒细胞巨噬细胞集落刺激因子（GM-CSF）刺激未成熟的骨髓前体细胞，但不刺激粒-巨噬细胞集落形成单位（CFU-GM）、粒细胞集落形成单位（CFU-G）或巨噬细胞集落形成单位（CFU-M）。
Exp Hematol. 1989 Mar;17(3):292-5.
10
Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.Flt3配体与粒细胞-巨噬细胞集落刺激因子或粒细胞集落刺激因子协同作用，将造血祖细胞动员到小鼠外周血中。
Blood. 1997 Nov 1;90(9):3781-8.

引用本文的文献

1
Cancer Chemotherapy: Combination with Inhibitors (Volume I).癌症化疗：与抑制剂联用（第一卷）
Cancers (Basel). 2024 Jan 31;16(3):607. doi: 10.3390/cancers16030607.
2
Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer.突破生理屏障与耐药性的疗法：一项关于鞘内注射曲妥珠单抗及新治疗方案能否改善HER2阳性乳腺癌软脑膜转移瘤肿瘤学结局的探索性研究及文献综述
Cancers (Basel). 2023 Apr 27;15(9):2508. doi: 10.3390/cancers15092508.

本文引用的文献

1
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.卡培他滨和替莫唑胺联合化疗治疗尼尔森综合征患者侵袭性垂体大腺瘤：病例报告。
Front Endocrinol (Lausanne). 2021 Nov 11;12:731631. doi: 10.3389/fendo.2021.731631. eCollection 2021.
2
Autocrine GMCSF Signaling Contributes to Growth of HER2 Breast Leptomeningeal Carcinomatosis.自分泌 GMCSF 信号促进 HER2 型乳腺癌脑膜转移瘤的生长。
Cancer Res. 2021 Sep 15;81(18):4723-4735. doi: 10.1158/0008-5472.CAN-21-0259. Epub 2021 Jul 9.
3
Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2 Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression.
抑制 Jumonji 组蛋白去甲基酶通过抑制 GMCSF 表达选择性抑制 HER2 乳腺癌软脑膜转移生长。
Cancer Res. 2021 Jun 15;81(12):3200-3214. doi: 10.1158/0008-5472.CAN-20-3317. Epub 2021 May 3.
4
Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.脑膜癌病：分子全景、当前管理和新兴疗法。
Neurosurg Clin N Am. 2020 Oct;31(4):613-625. doi: 10.1016/j.nec.2020.06.010.
5
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.脑脊液肿瘤细胞的检测及其在乳腺癌软脑膜转移中的临床意义
Breast Cancer Res Treat. 2015 Nov;154(2):339-49. doi: 10.1007/s10549-015-3610-1. Epub 2015 Oct 31.
6
Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.乳腺癌软脑膜转移对甲氨蝶呤后挽救性鞘内注射依托泊苷的持久反应：一例报告及文献综述
Am J Case Rep. 2015 Aug 10;16:524-7. doi: 10.12659/AJCR.894007.
7
Leptomeningeal carcinomatosis.柔脑膜癌病
Cancer Treat Rev. 1999 Apr;25(2):103-19. doi: 10.1053/ctrv.1999.0119.